{
    "nctId": "NCT00859989",
    "briefTitle": "A Weight-Loss Program in Helping Obese Black Women Lose Weight",
    "officialTitle": "Obesity Reduction Black Intervention Trial (ORBIT)",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer, Obesity, Weight Changes",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "N/A",
    "enrollmentCount": 200,
    "primaryOutcomeMeasure": "Body mass index as assessed at baseline, 24 weeks, and 18 months",
    "eligibilityCriteria": "DISEASE CHARACTERISTICS:\n\n* Self-identified as Black or African-American\n* Body mass index \u2265 30 kg/m\u00b2\n\nPATIENT CHARACTERISTICS:\n\n* Pre- or perimenopausal\n* Not pregnant or nursing\n* Not planning to become pregnant\n* Not planning to move from the Chicago area during the active and maintenance study interventions (18 months)\n* No exercise intolerance due to chronic obstructive pulmonary disease (e.g., emphysema, chronic bronchitis, or exercise-induced asthma)\n* No cancer requiring treatment within the past 5 years, except nonmelanoma skin cancer\n* No diabetes\n* No uncontrolled hypertension\n\n  * Participants on hypertensive medication may be eligible upon approval by the Investigator\n* None of the following conditions:\n\n  * Unstable angina\n  * Orthostatic hypotension\n  * Moderate to severe aortic stenosis\n  * Uncontrolled arrhythmia\n  * Uncontrolled congestive heart failure\n  * Pulmonary embolism within the past 6 months\n  * History of cardiac arrest\n* No significant mental illness (e.g., schizophrenia or unmedicated bipolar disorder)\n* No alcohol intake of \\> 2 drinks per day\n* No illegal drug use\n* No laxative abuse (i.e., \\> twice the recommended dose)\n\nPRIOR CONCURRENT THERAPY:\n\n* No concurrent treatment for an eating disorder\n* No concurrent medications (e.g., hormone-replacement therapy) that could interfere with adherence to an exercise program or could interfere with study outcomes\n* No concurrent participation in a formal weight-loss program\n* No concurrent pharmacotherapy for weight loss",
    "sex": "FEMALE",
    "minimumAge": "30 Years",
    "stdAges": "ADULT"
}